| Page 1022 | Kisaco Research
 

Tim Walsh

Research Director
Oxford University

Professor Tim Walsh has been studying antimicrobial resistance (AMR) mechanisms for over 25 years and publishes regularly in Nature and Lancet journals. Notably, in his career he has discovered and named two of the most notorious antibiotic resistant genes – NDM-1 and MCR-1. His work also helped discover the mobile tigecycline gene (tetX variant).

Read full bio

Tim Walsh

Research Director
Oxford University

Tim Walsh

Research Director
Oxford University

Professor Tim Walsh has been studying antimicrobial resistance (AMR) mechanisms for over 25 years and publishes regularly in Nature and Lancet journals. Notably, in his career he has discovered and named two of the most notorious antibiotic resistant genes – NDM-1 and MCR-1. His work also helped discover the mobile tigecycline gene (tetX variant).

 

Vikas Aggarwal

Regional Director, Asia
Fleming Fund

Vikas Aggarwal

Regional Director, Asia
Fleming Fund

Vikas Aggarwal

Regional Director, Asia
Fleming Fund
 

Toby Leslie

Health Specialist
Fleming Fund

Toby Leslie

Health Specialist
Fleming Fund

Toby Leslie

Health Specialist
Fleming Fund
 

Martin Sutherland

Director and General Manager
IDEXX

Martin Sutherland

Director and General Manager
IDEXX

Martin Sutherland

Director and General Manager
IDEXX
 

Sioned Timothy

Technical Services Manager- Livestock
Boehringer Ingelheim

Sioned Timothy

Technical Services Manager- Livestock
Boehringer Ingelheim

Sioned Timothy

Technical Services Manager- Livestock
Boehringer Ingelheim
 

Trine Vatle

Director Strategy and Operations
PHARMAQ

Trine Vatle

Director Strategy and Operations
PHARMAQ

Trine Vatle

Director Strategy and Operations
PHARMAQ
 

Tiffany Wood

Co-Founder and CEO
Dyneval

Tiffany Wood

Co-Founder and CEO
Dyneval

Tiffany Wood

Co-Founder and CEO
Dyneval
 

Andrea Iucci

Senior Vice President Europe
IDEXX

Andrea Iucci

Senior Vice President Europe
IDEXX

Andrea Iucci

Senior Vice President Europe
IDEXX

Danjuma Adda

I signed up to AMR Connect for the following: To share challenges of containing AMR in out-patient and community settings, especially in Africa. To have a platform to network and learn new and best practices on improving awareness and behavior change on AMR at community level and to share the results of our AMS activities in Nigeria.

Danjuma Adda

I signed up to AMR Connect for the following: To share challenges of containing AMR in out-patient and community settings, especially in Africa. To have a platform to network and learn new and best practices on improving awareness and behavior change on AMR at community level and to share the results of our AMS activities in Nigeria.